Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

PURPOSE: Sensitivity to a tyrosine kinase inhibitor (TKI) is correlated with the presence of somatic mutations that affect the kinase domain of epidermal growth factor receptor (EGFR). Development of resistance to TKI is a major therapeutic problem in non-small cell lung cancer (NSCLC). Aim of this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sudo, Makoto, Chin, Tan Min, Mori, Seiichi, Doan, Ngan B., Said, Jonathan W., Akashi, Makoto, Koeffler, H. Phillip
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3636434/
https://ncbi.nlm.nih.gov/pubmed/23515752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2132-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak